Furthermore, high NONO levels were associated with a poorer prognosis in TNBC or basal-like tumor patients who had undergone chemotherapy or radiation treatments (Figure S9A), and both NONO and STAT3 expression was also found to contribute to drug resistance (Figure 6C and S9B). The gene discussed is STAT3; the disease is neoplasm.